Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by 858 Therapeutics

News headline image
858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, Platinum-Resistant Ovarian Cancer
From 858 Therapeutics
Via Business Wire
News headline image
858 Therapeutics Announces $50 Million Series B Financing
From 858 Therapeutics
Via Business Wire
News headline image
858 Therapeutics to Present Preclinical Data on ETX-19477 at the AACR 2024 Annual Meeting
From 858 Therapeutics
Via Business Wire
News headline image
858 Therapeutics Expands Leadership Team to Support Transition to the Clinic
From 858 Therapeutics
Via Business Wire
News headline image
858 Therapeutics Expands Board of Directors and Leadership Team
From 858 Therapeutics
Via Business Wire
News headline image
858 Therapeutics Launches with Proven Team and $60 Million Series A Financing
From 858 Therapeutics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.